Ten glucose metabolism-related biomarker genes (B4GALT7, CHST12, G6PC2, GALE, IL13RA1, LDHB, SPAG4, STC1, TGFBI, and TPBG) were found to be statistically and biologically significant in the discrimination of LGGs from GBM in this study (Table 1). This evidence concerns the gene CHST12 and glioblastoma.